Literature DB >> 15361845

A novel p21WAF1/CIP1 transcript is highly dependent on p53 for its basal expression in mouse tissues.

Andrei L Gartel1, Senthil K Radhakrishnan, Michael S Serfas, Young H Kwon, Angela L Tyner.   

Abstract

p21WAF1/CIP1 is an important transcriptional target of p53 and it plays a critical role in growth arrest after DNA damage. Here, we report the identification of a novel alternate mouse p21 transcript that is conserved in evolution. It differs from the classical p21WAF1/CIP1 transcript in the first exon, which is located at approximately 2.8 kb upstream of transcriptional start site of p21WAF1/CIP1 and is sandwiched between two p53 binding sites. This novel p21 transcript is present in most mouse tissues with highest levels of expression in the spleen. In contrast to the classical p21WAF1/CIP1 transcript, this new transcript is highly dependent on p53 for its basal expression, as evidenced by its absence in nearly all of p53-/- mouse tissues. This transcript is also absent at nonpermissive temperature in a 10-1 mouse cell line lacking endogenous p53 and harboring temperature-sensitive p53 mutant. However, this novel transcript is induced to appreciable levels in the presence of high p53 activity at the permissive temperature. Our data suggest that p53-dependent induction of p21 may be an additive effect conferred by individual increases in the alternate and classical p21 transcripts.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15361845     DOI: 10.1038/sj.onc.1207820

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Deacetylase inhibitors - focus on non-histone targets and effects.

Authors:  Matthias Ocker
Journal:  World J Biol Chem       Date:  2010-05-26

2.  Ah receptor-mediated suppression of liver regeneration through NC-XRE-driven p21Cip1 expression.

Authors:  Daniel P Jackson; Hui Li; Kristen A Mitchell; Aditya D Joshi; Cornelis J Elferink
Journal:  Mol Pharmacol       Date:  2014-01-15       Impact factor: 4.436

3.  Establishment of a dog model for the p53 family pathway and identification of a novel isoform of p21 cyclin-dependent kinase inhibitor.

Authors:  Jin Zhang; Xiangling Chen; Michael S Kent; Carlos O Rodriguez; Xinbin Chen
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

4.  Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury.

Authors:  Robert J George; Mark A Sturmoski; Randal May; Sripathi M Sureban; Brian K Dieckgraefe; Shrikant Anant; Courtney W Houchen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-12-04       Impact factor: 4.052

Review 5.  Examination of the expanding pathways for the regulation of p21 expression and activity.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  Cell Signal       Date:  2010-01-25       Impact factor: 4.315

6.  Transcriptional regulation of the cyclin-dependent kinase inhibitor 1A (p21) gene by NFI in proliferating human cells.

Authors:  Stéphane Ouellet; François Vigneault; Maryse Lessard; Steeve Leclerc; Régen Drouin; Sylvain L Guérin
Journal:  Nucleic Acids Res       Date:  2006-11-27       Impact factor: 16.971

7.  Translational Upregulation of an Individual p21Cip1 Transcript Variant by GCN2 Regulates Cell Proliferation and Survival under Nutrient Stress.

Authors:  Stacey L Lehman; George J Cerniglia; Gregg J Johannes; Jiangbin Ye; Sandra Ryeom; Constantinos Koumenis
Journal:  PLoS Genet       Date:  2015-06-23       Impact factor: 5.917

8.  Insight into Bortezomib Focusing on Its Efficacy against P-gp-Positive MDR Leukemia Cells.

Authors:  Tomáš Kyca; Lucia Pavlíková; Viera Boháčová; Anton Mišák; Alexandra Poturnayová; Albert Breier; Zdena Sulová; Mário Šereš
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.